Chemours(US:CC) Prnewswire·2026-02-26 20:18Core Insights - Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company regarding potential securities fraud or unlawful business practices [1] - Chemours reported a significant decline in its stock price following the announcement of its fourth quarter and full year 2025 financial results, which included a one-time inventory charge affecting EBITDA [1] Financial Performance - Chemours disclosed that its 2025 EBITDA was negatively impacted by a one-time inventory charge in the Advanced Performance Materials segment [1] - The company cited "short-term cyclical end market headwinds" as a contributing factor to the financial results [1] - Following the financial report, Chemours's stock price fell by $3.37 per share, or 16.51%, closing at $17.04 per share on February 20, 2026 [1]